
|Videos|April 4, 2019
Entinostat Plus Pembrolizumab Shows Promise in Previously Treated Melanoma
Author(s)Ryan J. Sullivan, MD
Cancer Network spoke with Ryan J. Sullivan, MD, about the efficacy and safety of entinostat plus pembrolizumab in patients previously treated with immunotherapy.
Advertisement
Cancer Network spoke with Ryan J. Sullivan, MD, about the efficacy and safety of entinostat plus pembrolizumab in patients previously treated with immunotherapy.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
Anbenitamab Injection Combo Meets pCR End Point in HER2+ Breast Cancer
2
Elucidating Bispecific Impact in Diffuse Large B-Cell Lymphoma
3
CAR-T Moves to the Front Line: Rethinking the Multiple Myeloma Sequence
4
Rewriting the Tumor Microenvironment With IL-12–Armored CAR T Cells
5






















































